Amino acid determinants for NMDA receptor inhibition by conantokin-T

Journal of Neurochemistry

Volumn 77, Issue 3, 2001, Pages 812-822

  Warder, Scott E ^a   Blandl, Tamas ^a   Klein, Rebecca C ^a   Castellino, Francis J ^a   Prorok, Mary ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

3H MK 801; Conantokin analogs; Conantokins; Helicity; NMDA receptor

Indexed keywords

4 CARBOXYGLUTAMIC ACID; AMINO ACID; CONANTOKIN T; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FOREBRAIN; NEUROCHEMISTRY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RECEPTOR BLOCKING; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; CELL MEMBRANE; CIRCULAR DICHROISM; DIZOCILPINE MALEATE; MICE; MODELS, MOLECULAR; MOLLUSK VENOMS; PEPTIDE FRAGMENTS; PEPTIDES; PROSENCEPHALON; PROTEIN CONFORMATION; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP; TRITIUM;

ANIMALIA;

EID: 0034999419     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00281.x     Document Type: Article

References (45)

1. Barbier J. R., Neugebauer W., Morley P., Ross V., Soska M., Whitfield J. F. and Willick G. (1997) Bioactivities and secondary structures of constrained analogues of human parathyroid hormone: cyclic lactams of the receptor binding region. J. Med. Chem 40, 1373-1380.
2. Benke T. A., Jones O. T., Collingridge G. L. and Angelides K. J. (1993) N-Methyl-D-aspartate receptors are clustered and immobilized on dendrites of living cortical neurons. Proc. Natl. Acad. Sci. USA. 90, 7819-7823.
3. Blandl T., Prorok M. and Castellino F. J. (1998) NMDA-receptor antagonist requirements in conantokin-G. FEBS Lett. 435, 257-262.
4. Blandl T., Warder S. E., Prorok M. and Castellino F. J. (1999) Binding of cations to individual γ-carboxyglutamate residues of conantokin-G and conantokin-T. J. Peptide Res. 53, 453-464.
5. Bliss T. V. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
6. Chandler P., Pennington M., Maccecchini M. L., Nashed N. T. and Skolnick P. (1993) Polyamine-like actions of peptides derived from conantokin G, an N-methyl-D-aspartate (NMDA) antagonist. J. Biol. Chem. 268, 171738.
7. Chang C.-F. and Zehfus M. H. (1996) The effect of N-methylation on helical peptides. Biopolymers 40, 609-616.
8. Chen Z. G., Blandl T., Prorok M., Warder S. E., Li L. P., Zhu Y., Pedersen L. G., Ni F. and Castellino F. J. (1998) Conformational changes in conantokin-G induced upon binding of calcium and magnesium as revealed by NMR structural analysis. J. Biol. Chem. 273, 16248-16258.
9. Chen Y.-H., Yang J. T. and Martinez H. M. (1972) Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 11, 4120-4131.
10. Colpitts T. L. and Castellino F. J. (1993) Binding of calcium to synthetic peptides containing gamma-carboxyglutamic acid. Int. J. Peptide Protein Res. 41, 567-575.
11. De Sarro G. and De Sarro A. (1992) Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats. Eur. J. Pharmacol. 215, 221-229.
12. Doble A., (1995) Excitatory amino acid receptors and neurodegeneration. Therapie 50, 319-337.
13. Donevan S. D. and McCabe R. T. (2000) Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors. Mol. Pharmacol. 58, 614-623.
14. Galdzicki Z., Coan E. and Rapoport S. I. (1993) Cultured hippocampal neurons from trisomy 16 mouse, a model for Down's syndrome, have an abnormal action potential due to a reduced inward sodium current. Brain Res. 604, 69-78.
15. Haack J. A., Rivier J., Parks T. N., Mena E. E., Cruz L. J. and Olivera B. M. (1990) Conantokin-T. A γ-carboxyglutamate-containing peptide with N-methyl-D-aspartate antagonist activity. J. Biol. Chem. 265, 6025-6029.
16. Haack J. A., Parks T. N. and Olivera B. M. (1993) Conantokin-G antagonism of the NMDA receptor subtype expressed in cultured cerebellar granule cells. Neurosci. Lett. 163, 63-66.
17. Hammerland L. G., Olivera B. M. and Yoshikami D. (1992) Conantokin-G selectively inhibits N-methyl-D-aspartate-induced currents in Xenopus oocytes injected with mouse brain mRNA. Eur. J. Pharmacol. 226, 239-244.
18. Hawkins L. M., Chazot P. L. and Stephenson F. A. (1999) Biochemical evidence for the co-association of three N-methyl-D-aspartate (NMDA) R2 subunits in recombinant NMDA receptors. J. Biol. Chem. 274, 27211-27218.
19. Jin D. H., Jung Y. W., Ham S. H., Ko B. H. and Moon I. S. (1997a) Developmental expression, subcellular localization, and tyrosine phosphorylation of NR2A and NR2B in the rat brain. Mol. Cells 7, 64-71.
20. Jin D. H., Jung Y. W., Ko B. H. and Moon I. S. (1997b) Immunoblot analyses on the differential distribution of NR2A and NR2B subunits in the adult rat brain. Mol. Cells 7, 749-754.
21. Klein R. C. and Castellino F. J. (1999) Inhibition of MK801 binding in adult rat brain sections by conantokin-G and conantokin-T. Neurosci. Lett. 273, 171-174.
22. Laube B., Kuhse J. and Betz H. (1998) Evidence for a tetrameric structure of recombinant NMDA receptors. J. Neurosci. 18, 2954-2961.
23. Luo J., Wang Y., Yasuda R. P., Dunah A. W. and Wolfe B. B. (1997) The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/ NR2A/NR2B). Mol. Pharmacol. 51, 79-86.
24. McIntosh J., Olivera B. M., Cruz L. and Gray W. (1984) γ-Carboxyglutamate in a neuroactive toxin. J. Biol. Chem. 259, 14343-14346.
25. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B. and Seeburg P. H. (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217-1221.
26. Monyer H., Burnashev N., Laurie D. J., Sakmann B. and Seeburg P. H. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540.
27. 2+ entry into neurons. J. Toxicol.-Toxin Rev. 9, 179-202.
28. Nielsen K. J., Skjaerbaek N., Dooley M., Adams D. A., Mortensen M., Dodd P. R., Craik D. J., Alewood P. F. and Lewis R. J. (1999) Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators. J. Med. Chem. 42, 415-426.
29. Otvos L. Jr, Bokoni G., Szendrei G. I., Varga I., Vasko M., Zhou L.-M., Skolnick P. and Maccecchini M.-L. (1997) The flexible termini of conantokin G define its interactions with NMDA receptors. Lett. Pept. Sci. 4, 85-93.
30. Premkumar L. S. and Auerbach A. (1997) Stoichiometry of recombinant N-methyl-D-aspartate receptor channels inferred from single-channel current patterns. J. Gen. Physiol. 110, 485-502.
31. Prorok M. and Castellino F. J. (1998) Thermodynamics of binding of calcium, magnesium, and zinc to the N-methyl-D-aspartate receptor ion channel peptidic inhibitors, conantokin-G and conantokin-T. J. Biol. Chem. 273, 19573-19578.
32. Prorok M., Warder S. E., Blandl T. and Castellino F. J. (1996) Calcium binding properties of synthetic γ-carboxyglutamic acid containing marine cone snail 'sleeper' peptides, conantokin-G and conantokin-T. Biochemistry 35, 16528-16534.
33. Ramachandran G. N. and Sasisekharan V. (1968) Conformation of polypeptides and proteins. Adv. Prot. Chem. 23, 283-437.
34. Rickard N. S., Poot A. C., Gibbs M. E. and Ng K. T. (1994) Both non-NMDA and NMDA glutamate receptors are necessary for memory consolidation in the day-old chick. Behav. Neural. Biol. 62, 33-40.
35. Skjærbæk N., Nielsen K. J., Lewis R. J., Alewood P. and Craik D. J. (1997) Determination of the solution structure of conantokin-G and conantokin-T by CD and NMR spectroscopy. J. Biol. Chem. 272, 2291-2299.
36. Skolnick P., Boje K., Miller R., Pennington M. and Maccecchini M.-L. (1992) Non-competitive inhibition of N-methyl-D-aspartate by conantokin-G: evidence for an allosteric interaction at polyamine sites. J. Neurochem. 59, 1516-1521.
37. Warder S. E., Chen Z., Zhu Y., Prorok M., Castellino F. J. and Ni F. (1997) The NMR solution structure of the NMDA receptor antagonist, conantokin-T, in the absence of divalent metal ions. FEBS Lett. 411, 19-26.
38. Warder S. E., Prorok M., Chen Z., Li L., Zhu Y., Pedersen L. G., Ni F. and Castellino F. J. (1998) The roles of individual γ-carboxyglutamate residues in the solution structure and cation-dependent properties of conantokin-T. J. Biol. Chem. 273, 7512-7522.
39. Watanabe M., Jnoue Y., Sakimura K. and Mishina M. (1992) Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3, 1138-1140.
40. White H. S., McCabe R. T., Armstrong H., Donevan S. D., Cruz L. J., Abogadie F. C., Torres J., Rivier J. E., Paarmann I., Hollman M. and Olivera B. M. (2000) In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. J. Pharmacol. Exp. Ther. 292, 425-432.
41. Williams K. (1993) Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44, 851-859.
42. Williams K. (1997) Modulation and block of ion channels: a new biology of polyamines. Cell Signal 9, 1-13.
43. Williams A. J., Dave J. R., Phillips J. B., Lin Y., McCabe R. T. and Tortella F. C. (2000) Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. J. Pharmacol. Exp. Ther. 294, 378-386.
44. Yamakura T. and Shimoji K. (1999) Subunit-and site-specific pharmacology of the NMDA receptor channel. Prog. Neurobiol. 59, 279-298.
45. Zhou L.-M., Szendrei G. I., Fossom L. H., Maccecchini M.-L., Skolnick P. and Otvos L. Jr (1996) Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site. J. Neurochem. 66, 620-628.